Royal Bank of Canada Lowers Sandoz Group (OTCMKTS:SDZNY) to Hold

Sandoz Group (OTCMKTS:SDZNY) was downgraded by research analysts at Royal Bank of Canada from a “moderate buy” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports.

Sandoz Group Stock Down 0.4 %

Shares of SDZNY stock opened at $40.78 on Monday. The business has a 50-day moving average of $41.75 and a 200 day moving average of $36.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.86 and a current ratio of 1.33. Sandoz Group has a 1-year low of $25.71 and a 1-year high of $44.98.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.